Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | DGKA | P23743 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9955144 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9956002 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9954639 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9954929 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9956324 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9955782 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9954828 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL9955180 | 1.00 | PLA2G2C (0.32) | PLA2G2CS1PR4S1PR1S1PR3CES2 | |
| SCHEMBL16341864 | 0.92 | — | — | |
| SCHEMBL9955644 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137591-A1 | COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS | ICU MEDICAL INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-3990037-B1 | LAYERED COLLAGEN DRESSING WITH EXTENDED BACTERIA AND BIOFILM REDUCING CAPABILITIES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-06-19 | — | — | EP | claimed |
| EP-3713979-B1 | MEDICAL DEVICES | SOLVAY SPECIALTY POLYMERS IT (IT) | 2024-03-06 | — | — | EP | claimed |
| US-20230399618-A1 | METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-12-14 | — | — | US | claimed |
| US-20230180741-A1 | DEHP-Free Blood Storage and Methods of Use Thereof | HEMANEXT INC. (US) | 2023-06-15 | — | — | US | claimed |
| US-11672890-B2 | Medical devices | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2023-06-13 | — | — | US | claimed |
| WO-2023086494-A1 | METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-05-19 | — | — | WO | claimed |
| EP-4149257-A2 | DEHP-FREE BLOOD STORAGE AND METHODS OF USE THEREOF | Hemanext Inc. (US) | 2023-03-22 | — | — | EP | claimed |
| WO-2021231650-A2 | DEHP-FREE BLOOD STORAGE AND METHODS OF USE THEREOF | HEMANEXT INC. (US) | 2021-11-18 | — | — | WO | claimed |
| US-11000551-B2 | Red blood cell products and the storage of red blood cells in containers free of phthalate plasticizer | FENWAL, INC. (US) | 2021-05-11 | — | — | US | claimed |
| EP-1299048-A4 | BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES | SHUKLA ATUL J (US) | 2005-09-28 | — | — | EP | claimed |
| EP-0996667-B1 | PLASTIC COMPOSITIONS INCLUDING VITAMIN E FOR MEDICAL CONTAINERS AND METHODS FOR PROVIDING SUCH COMPOSITIONS AND CONTAINERS | BAXTER INT (US) | 2004-08-25 | — | — | EP | claimed |
| JP-2004511431-A | — | — | 2004-04-15 | — | — | JP | claimed |
| US-20040018238-A1 | Biodegradable vehicles and delivery systems of biolgically active substances | SHUKLA ATUL J (US) | 2004-01-29 | — | — | US | claimed |
| EP-1299048-A1 | BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES | Shukla, Atul J. (US) | 2003-04-09 | — | — | EP | claimed |
| EP-0996677-B1 | PLASTIC COMPOSITIONS FOR MEDICAL CONTAINERS AND METHODS FOR PROVIDING SUCH CONTAINERS AND FOR STORING RED BLOOD CELLS | BAXTER INT (US) | 2002-11-20 | — | — | EP | claimed |
| US-6432438-B1 | BLENDING CO- OR HOMOPOLYMERS, PLASTICIZERS AND DRUGS TO FORM A DRUG DELIVERY SYSTEM, HAVING DOSAGE FLEXIBILITY AND STABILITY; TIME-RELEASE AGENTS | SHUKLA ATUL J (US) | 2002-08-13 | — | — | US | claimed |
| WO-2002000137-A1 | BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES | SHUKLA ATUL J (US) | 2002-01-03 | — | — | WO | claimed |
| EP-0516818-B1 | IMPROVED MATERIAL FOR MEDICAL GRADE TUBING | BAXTER INT (US) | 1998-08-12 | — | — | EP | claimed |
| EP-0138147-B1 | CITRATE-ESTER PLASTICIZED PVC BLOOD CONTAINERS | Bayer Corporation (US) | 1993-04-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137591-A1 | COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS | TFEB, LAGE3, RICTOR | PLA2G2C 3717/4885S1PR4 4151/4885S1PR1 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.